Interleukin-12 Antagonist [EPC]

54665 reported adverse events

Drugs of this class: USTEKINUMAB

These side effects are most commonly reported by patients taking drugs of the Interleukin-12 Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 6669
1 OFF LABEL USE 4977
2 PSORIASIS 4495
3 PRODUCT USE ISSUE 2497
4 CROHN^S DISEASE 2442
5 PNEUMONIA 2095
6 DRUG DOSE OMISSION 1984
7 LOWER RESPIRATORY TRACT INFECTION 1953
8 HEADACHE 1805
9 FATIGUE 1732
See all common reactions for Interleukin-12 Antagonist [EPC]

Drugs of the Interleukin-12 Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RED BLOOD CELL SEDIMENTATION RATE 33 0.3056
1 SWOLLEN JOINT COUNT INCREASED 29 0.2566
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 212 0.2431
3 CONTRAINDICATION TO VACCINATION 34 0.2166
4 ENTHESOPATHY 145 0.1975
5 PROCTECTOMY 16 0.1778
6 ILEECTOMY 27 0.1475
7 ERYTHRODERMIC PSORIASIS 79 0.1452
8 RHEUMATOID FACTOR POSITIVE 202 0.1348
9 SYRINGE ISSUE 788 0.1309
See all enriched reactions for Interleukin-12 Antagonist [EPC]